BIIB - CIK 0000875045
The table below shows BIOGEN INC.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | - | - | - | - | - | - |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $1.34B | $1.40B | $1.66B | $1.71B | $1.55B | $1.91B |
| Inventory | $2.17B | $2.46B | $2.53B | $1.34B | $1.35B | $1.07B |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $8.97B |
| $7.46B |
| $6.86B |
| $9.79B |
| $7.86B |
| $6.89B |
| Property, plant & equipment | $3.06B | $3.18B | $3.31B | $3.30B | $3.42B | $3.41B |
| Goodwill | $6.49B | $6.48B | $6.22B | $5.75B | $5.76B | $5.76B |
| Total assets | $29.44B | $28.05B | $26.84B | $24.55B | $23.88B | $24.62B |
| Accounts payable | $432.00M | $424.20M | $403.30M | $491.50M | $589.20M | $454.90M |
| Total current liabilities | $3.35B | $5.53B | $3.43B | $3.27B | $4.30B | $3.74B |
| Long-term debt | $6.29B | $6.30B | $6.94B | $6.28B | $6.27B | $7.43B |
| Total liabilities | $11.18B | $11.33B | $12.05B | $11.17B | $12.92B | $13.93B |
| Retained earnings | $20.55B | $19.26B | $17.63B | $16.47B | $13.91B | $13.98B |
| Total equity | - | - | $14.80B | $13.40B | $10.90B | $10.70B |